Sebacia

9 articles with Sebacia

• Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months

  10/11/2018

  Oral presentation today at ASDS Annual Meeting by leading dermatologist Ashish Bhatia, MD

• Sebacia Highlights Oral Presentation of EU Real-World Pre-Conditioning Study Results at ASDS Annual Meeting 2018

  10/8/2018

  Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that results from its real-world pre-conditioning study in Europe evaluating Sebacia Microparticles for treatment of facial acne has been accepted for an oral presentation

• U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne

  9/17/2018

  U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019

• Sebacia Announces Presentation of Data Demonstrating Sebacia Microparticles as an Effective Contrast Enhancing Agent for Potential Use in Evaluating Dermatologic Conditions

  4/9/2018

  Sebacia, Inc. will present data showing Sebacia Microparticles could help improve dermatologic imaging by acting as a contrast enhancing agent.

• Sebacia Announces $36 Million Equity And Debt Financing To Advance Breakthrough In-Office Procedure For Acne

  7/25/2017

• Sebacia Announces Completion Of Enrollment In Pivotal U.S. Clinical Trial For Severe Acne

  10/7/2015

• Sebacia Announces Series C Financing To Advance Innovative Dermatology Treatment For Acne

  6/25/2015

• Sebacia Announces New Vice President, Engineering And Program Management

  6/25/2015

• Sebacia Release: Study Points Way To New Treatment Procedure For Acne

  3/20/2015